These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 32330874)

  • 1. Volatomics in inflammatory bowel disease and irritable bowel syndrome.
    Van Malderen K; De Winter BY; De Man JG; De Schepper HU; Lamote K
    EBioMedicine; 2020 Apr; 54():102725. PubMed ID: 32330874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study.
    Bosch S; van Gaal N; Zuurbier RP; Covington JA; Wicaksono AN; Biezeveld MH; Benninga MA; Mulder CJ; de Boer NKH; de Meij TGJ
    Inflamm Bowel Dis; 2018 Oct; 24(11):2468-2475. PubMed ID: 29788410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volatile organic compounds in breath as markers for irritable bowel syndrome: a metabolomic approach.
    Baranska A; Mujagic Z; Smolinska A; Dallinga JW; Jonkers DM; Tigchelaar EF; Dekens J; Zhernakova A; Ludwig T; Masclee AA; Wijmenga C; van Schooten FJ
    Aliment Pharmacol Ther; 2016 Jul; 44(1):45-56. PubMed ID: 27136066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volatile organic compounds as potential biomarkers of irritable bowel syndrome: A systematic review.
    Zhang VR; Ramachandran GK; Loo EXL; Soh AYS; Yong WP; Siah KTH
    Neurogastroenterol Motil; 2023 Jul; 35(7):e14536. PubMed ID: 36780514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome.
    Däbritz J; Musci J; Foell D
    World J Gastroenterol; 2014 Jan; 20(2):363-75. PubMed ID: 24574706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing Inflammatory bowel disease using noninvasive applications of volatile organic compounds: a systematic review.
    Bannaga AS; Farrugia A; Arasaradnam RP
    Expert Rev Gastroenterol Hepatol; 2019 Nov; 13(11):1113-1122. PubMed ID: 31657950
    [No Abstract]   [Full Text] [Related]  

  • 7. Faecal volatile organic compounds analysis using field asymmetric ion mobility spectrometry: non-invasive diagnostics in paediatric inflammatory bowel disease.
    van Gaal N; Lakenman R; Covington J; Savage R; de Groot E; Bomers M; Benninga M; Mulder C; de Boer N; de Meij T
    J Breath Res; 2017 Nov; 12(1):016006. PubMed ID: 28439048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study.
    Patel N; Alkhouri N; Eng K; Cikach F; Mahajan L; Yan C; Grove D; Rome ES; Lopez R; Dweik RA
    Aliment Pharmacol Ther; 2014 Sep; 40(5):498-507. PubMed ID: 25041596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive exhaled volatile organic biomarker analysis to detect inflammatory bowel disease (IBD).
    Arasaradnam RP; McFarlane M; Daulton E; Skinner J; O'Connell N; Wurie S; Chambers S; Nwokolo C; Bardhan K; Savage R; Covington J
    Dig Liver Dis; 2016 Feb; 48(2):148-53. PubMed ID: 26682719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
    Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP
    Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation of fecal volatile organic metabolites in irritable bowel syndrome.
    Ahmed I; Greenwood R; Costello Bde L; Ratcliffe NM; Probert CS
    PLoS One; 2013; 8(3):e58204. PubMed ID: 23516449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D
    Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extending landscape of volatile metabolites as novel diagnostic biomarkers of inflammatory bowel disease - a review.
    Ahmed I; Fayyaz F; Nasir M; Niaz Z; Furnari M; Perry L
    Scand J Gastroenterol; 2016; 51(4):385-92. PubMed ID: 26541790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irritable bowel syndrome and active inflammatory bowel disease diagnosed by faecal gas analysis.
    Aggio RB; White P; Jayasena H; de Lacy Costello B; Ratcliffe NM; Probert CS
    Aliment Pharmacol Ther; 2017 Jan; 45(1):82-90. PubMed ID: 27862117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile and fat excretion are biomarkers of clinically significant diarrhoea and constipation in irritable bowel syndrome.
    Vijayvargiya P; Camilleri M; Burton D; Busciglio I; Lueke A; Donato LJ
    Aliment Pharmacol Ther; 2019 Mar; 49(6):744-758. PubMed ID: 30740753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel Syndrome.
    Rossi M; Aggio R; Staudacher HM; Lomer MC; Lindsay JO; Irving P; Probert C; Whelan K
    Clin Gastroenterol Hepatol; 2018 Mar; 16(3):385-391.e1. PubMed ID: 28993261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The faecal scent of inflammatory bowel disease: Detection and monitoring based on volatile organic compound analysis.
    Bosch S; Wintjens DSJ; Wicaksono A; Kuijvenhoven J; van der Hulst R; Stokkers P; Daulton E; Pierik MJ; Covington JA; de Meij TGJ; de Boer NKH
    Dig Liver Dis; 2020 Jul; 52(7):745-752. PubMed ID: 32402741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva.
    Amann A; Costello Bde L; Miekisch W; Schubert J; Buszewski B; Pleil J; Ratcliffe N; Risby T
    J Breath Res; 2014 Sep; 8(3):034001. PubMed ID: 24946087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of fecal volatile organic compounds as biomarkers of chemically induced intestinal inflammation in mice.
    Reade S; Williams JM; Aggio R; Duckworth CA; Mahalhal A; Hough R; Pritchard DM; Probert CS
    FASEB J; 2019 Mar; 33(3):3129-3136. PubMed ID: 30359099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome.
    Zhu S; Liu S; Li H; Zhang Z; Zhang Q; Chen L; Zhao Y; Chen Y; Gu J; Min L; Zhang S
    Front Cell Infect Microbiol; 2019; 9():346. PubMed ID: 31681624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.